Nine‐year trend of oral anticoagulant use in patients with embolic stroke due to nonvalvular atrial fibrillation

BACKGROUND: Direct oral anticoagulants (DOACs) are increasingly used as an alternative to warfarin in patients with nonvalvular atrial fibrillation (NVAF). However, whether there is sufficient prescription of oral anticoagulants (OACs) to decrease the incidence of embolic stroke remains unclear. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Asahina, Chisa, Umetani, Ken, Sano, Keita, Yano, Toshiaki, Nakano, Shin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532266/
https://www.ncbi.nlm.nih.gov/pubmed/33024465
http://dx.doi.org/10.1002/joa3.12402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532266/
https://www.ncbi.nlm.nih.gov/pubmed/33024465
http://dx.doi.org/10.1002/joa3.12402

Ejemplares similares